Your browser doesn't support javascript.
loading
TOX is a critical regulator of tumour-specific T cell differentiation.
Scott, Andrew C; Dündar, Friederike; Zumbo, Paul; Chandran, Smita S; Klebanoff, Christopher A; Shakiba, Mojdeh; Trivedi, Prerak; Menocal, Laura; Appleby, Heather; Camara, Steven; Zamarin, Dmitriy; Walther, Tyler; Snyder, Alexandra; Femia, Matthew R; Comen, Elizabeth A; Wen, Hannah Y; Hellmann, Matthew D; Anandasabapathy, Niroshana; Liu, Yong; Altorki, Nasser K; Lauer, Peter; Levy, Olivier; Glickman, Michael S; Kaye, Jonathan; Betel, Doron; Philip, Mary; Schietinger, Andrea.
Afiliación
  • Scott AC; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Dündar F; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.
  • Zumbo P; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
  • Chandran SS; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA.
  • Klebanoff CA; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
  • Shakiba M; Applied Bioinformatics Core, Weill Cornell Medicine, New York, NY, USA.
  • Trivedi P; Parker Institute for Cancer Immunotherapy, New York, NY, USA.
  • Menocal L; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Appleby H; Parker Institute for Cancer Immunotherapy, New York, NY, USA.
  • Camara S; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Zamarin D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Walther T; Weill Cornell Medical College, New York, NY, USA.
  • Snyder A; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Femia MR; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
  • Comen EA; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Wen HY; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hellmann MD; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.
  • Anandasabapathy N; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Liu Y; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Altorki NK; Parker Institute for Cancer Immunotherapy, New York, NY, USA.
  • Lauer P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Levy O; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Glickman MS; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Kaye J; Parker Institute for Cancer Immunotherapy, New York, NY, USA.
  • Betel D; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Philip M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Schietinger A; Weill Cornell Medical College, New York, NY, USA.
Nature ; 571(7764): 270-274, 2019 07.
Article en En | MEDLINE | ID: mdl-31207604

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas del Grupo de Alta Movilidad / Diferenciación Celular / Proteínas de Homeodominio / Linfocitos T CD8-positivos / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nature Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas del Grupo de Alta Movilidad / Diferenciación Celular / Proteínas de Homeodominio / Linfocitos T CD8-positivos / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nature Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
...